Founded in Sweden in 2005, and with operations in 13 European countries, Bluefish Pharmaceuticals has become one of the world’s most progressive generic pharmaceuticals companies. CEO Berit Lindholm explains how Bluefish strives to compete on service rather than price by being a reliable partner to health authorities. She also emphasises the role of talented people able to take fast and flexible decisions in the continued commercial success of the company.
At Bluefish we believe that price competitiveness is not the only key success factor in the generics business
